alpha-L-Fucp-(1->3)-[beta-D-Galp4F-(1->4)]-beta-D-GlcpNAc-OMe

Term ID

CHEBI:77196

Synonyms

4''-deoxyfluoro Le(x)OMe
alpha-L-Fuc-(1->3)-[beta-D-Gal4F-(1->4)]-beta-D-GlcNAc-OMe
methyl 4-deoxy-4-fluoro-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranoside
methyl 4-deoxy-4-fluoro-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranoside
methyl 4-deoxy-4-fluoro-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-beta-D-glucosaminide

Definition

A methyl glycoside that is alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc (Le(x)) in which the galactose 4-OH is replaced by fluorine and the hydroxy group at the reducing-end anomeric centre is methylated.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: methyl glycoside trisaccharide derivative

methyl glycoside trisaccharide derivative Show first 5 Terms
has_functional_parent: alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc

alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->3)-[beta-D-Galp4F-(1->4)]-beta-D-GlcpNAc-OMe

Phenotype where environments contain alpha-L-Fucp-(1->3)-[beta-D-Galp4F-(1->4)]-beta-D-GlcpNAc-OMe

Phenotype modified by environments containing alpha-L-Fucp-(1->3)-[beta-D-Galp4F-(1->4)]-beta-D-GlcpNAc-OMe

Human Disease Model